10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2018 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 22, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 3,844 | 9,407 |
| Investments, primarily bank time deposits and U.S. treasury bills | 242 | 203 |
| Trade receivables, less allowances of - 2018: $314; 2017: $294 | 5,182 | 5,249 |
| Inventories: | ||
| Finished products | 2,407 | 2,339 |
| Work in process | 499 | 472 |
| Materials | 890 | 790 |
| Total inventories | 3,796 | 3,601 |
| Prepaid expenses and other receivables | 1,559 | 1,667 |
| Current assets held for disposition | 9 | 20 |
| Total Current Assets | 14,632 | 20,147 |
| Investments | 897 | 883 |
| Property and Equipment, at Cost: | ||
| Land | 501 | 526 |
| Buildings | 3,555 | 3,613 |
| Equipment | 10,756 | 10,394 |
| Construction in progress | 894 | 732 |
| Property and equipment, at cost | 15,706 | 15,265 |
| Less: accumulated depreciation and amortization | 8,143 | 7,658 |
| Net Property and Equipment | 7,563 | 7,607 |
| Intangible Assets, net of amortization | 18,942 | 21,473 |
| Goodwill | 23,254 | 24,020 |
| Deferred Income Taxes and Other Assets | 1,868 | 1,944 |
| Non-current Assets Held for Disposition | 17 | 176 |
| Total Assets | 67,173 | 76,250 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 200 | 206 |
| Trade accounts payable | 2,975 | 2,402 |
| Salaries, wages and commissions | 1,182 | 1,187 |
| Other accrued liabilities | 3,780 | 3,811 |
| Dividends payable | 563 | 489 |
| Income taxes payable | 305 | 309 |
| Current portion of long-term debt | 7 | 508 |
| Total Current Liabilities | 9,012 | 8,912 |
| Long-term Debt | 19,359 | 27,210 |
| Post-employment obligations, deferred income taxes and other long-term liabilities | 8,080 | 9,030 |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2018: 1,971,189,465; 2017: 1,965,908,188 | 23,512 | 23,206 |
| Common shares held in treasury, at cost - Shares: 2018: 215,570,043; 2017: 222,305,719 | (9,962) | (10,225) |
| Earnings employed in the business | 24,560 | 23,978 |
| Accumulated other comprehensive income (loss) | (7,586) | (6,062) |
| Total Abbott Shareholders' Investment | 30,524 | 30,897 |
| Noncontrolling Interests in Subsidiaries | 198 | 201 |
| Total Shareholders' Investment | 30,722 | 31,098 |
| Total Liabilities and Shareholders' Investment | 67,173 | 76,250 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |